88 related articles for article (PubMed ID: 19853975)
1. [Antibiotic use in patients with renal or hepatic failure].
Ramón Azanza J; García E; Sádaba B; Manubens A
Enferm Infecc Microbiol Clin; 2009 Dec; 27(10):593-9. PubMed ID: 19853975
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic pharmacokinetics in newborns.
Smith AL
Mead Johnson Symp Perinat Dev Med; 1982; (21):52-6. PubMed ID: 6765460
[TBL] [Abstract][Full Text] [Related]
3. Single-dose pharmacokinetics of teicoplanin during hemodialysis therapy using high-flux polysulfone membranes.
Thalhammer F; Rosenkranz AR; Burgmann H; Graninger W; Hollenstein U; Schenk P; Thalhammer-Scherrer R; Traindl O; Hörl WH; Breyer S
Wien Klin Wochenschr; 1997 May; 109(10):362-5. PubMed ID: 9200809
[TBL] [Abstract][Full Text] [Related]
4. Use of antibacterial agents in renal failure.
Livornese LL; Slavin D; Gilbert B; Robbins P; Santoro J
Infect Dis Clin North Am; 2004 Sep; 18(3):551-79, viii-ix. PubMed ID: 15308276
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of dalbavancin in patients with renal or hepatic impairment.
Marbury T; Dowell JA; Seltzer E; Buckwalter M
J Clin Pharmacol; 2009 Apr; 49(4):465-76. PubMed ID: 19318696
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacokinetics and clearance of ciprofloxacin and amikacin in continuous hemodialysis].
Cotera A; Aguila R; Gaete L; Saffie A; Lorca E; Thambo S
Rev Med Chil; 1995 Jun; 123(6):742-8. PubMed ID: 8525228
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic dosing in patients with renal insufficiency or receiving dialysis.
Cunha BA; Friedman PE
Heart Lung; 1988 Nov; 17(6 Pt 1):612-6. PubMed ID: 3056882
[TBL] [Abstract][Full Text] [Related]
8. [Antimicrobial agents in pediatric cancer patients with hepatic or renal impairment].
Kolve H; Silling G; Ritter J; Groll AH
Klin Padiatr; 2005 Nov; 217 Suppl 1():S150-64. PubMed ID: 16288361
[TBL] [Abstract][Full Text] [Related]
9. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
10. Antiarrhythmic drug therapy in patients with renal failure, liver failure, and congestive heart failure.
Chow T; Galvin J; McGovern B
Heart Dis; 1999; 1(2):98-107. PubMed ID: 11720610
[TBL] [Abstract][Full Text] [Related]
11. Dosing strategy in patients with renal failure receiving enoxaparin for the treatment of non-ST-segment elevation acute coronary syndrome.
Hulot JS; Montalescot G; Lechat P; Collet JP; Ankri A; Urien S
Clin Pharmacol Ther; 2005 Jun; 77(6):542-52. PubMed ID: 15961985
[TBL] [Abstract][Full Text] [Related]
12. Clearance of vancomycin during high-efficiency hemodialysis.
Klansuwan N; Ratanajamit C; Kasiwong S; Wangsiripaisan A
J Med Assoc Thai; 2006 Jul; 89(7):986-91. PubMed ID: 16881431
[TBL] [Abstract][Full Text] [Related]
13. Effects of renal failure on drug transport and metabolism.
Sun H; Frassetto L; Benet LZ
Pharmacol Ther; 2006 Jan; 109(1-2):1-11. PubMed ID: 16085315
[TBL] [Abstract][Full Text] [Related]
14. [Antibacterial chemotherapy in renal failure].
Briedigkeit H
Z Urol Nephrol; 1983 May; 76(5):349-52. PubMed ID: 6880421
[No Abstract] [Full Text] [Related]
15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
16. [Drug dosage in renal failure -- traps and aids].
Aymanns C; Keller F
Med Klin (Munich); 2004 Oct; 99(10):613-24; quiz 625. PubMed ID: 15490077
[No Abstract] [Full Text] [Related]
17. Principles of antibacterial dosing in continuous renal replacement therapy.
Choi G; Gomersall CD; Tian Q; Joynt GM; Freebairn R; Lipman J
Crit Care Med; 2009 Jul; 37(7):2268-82. PubMed ID: 19487930
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of ceftriaxone in patients with renal and liver insufficiency and correlations with a physiologic nonlinear protein binding model.
Stoeckel K; Koup JR
Am J Med; 1984 Oct; 77(4C):26-32. PubMed ID: 6093514
[TBL] [Abstract][Full Text] [Related]
19. [Clinical pharmacokinetics of azithromycin].
Singlas E
Pathol Biol (Paris); 1995 Jun; 43(6):505-11. PubMed ID: 8539072
[TBL] [Abstract][Full Text] [Related]
20. Consequences of renal insufficiency on the hepatic clearance of some drugs.
Balant LP; Dayer P; Fabre J
Int J Clin Pharmacol Res; 1983; 3(6):459-74. PubMed ID: 6147317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
